For example, >50% of the prognostically favourable (and frequently microsatellite-instable) medullary carcinomas as well as almost all of the biologically highly aggressive MANEC/NECs fell into the CDX2-low/absent subgroup. The gene discussed is CDX2; the disease is medullary thyroid gland carcinoma.